The role of thyroid dysfunction in the critically ill: A review of the literature

Minerva Anestesiologica

Volumn 76, Issue 11, 2010, Pages 919-928

  Bello, G ^a   Ceaichisciuc, I ^a   Silva, S ^a   Antonelli, M ^a  

^a FONDAZIONE POLICLINICO UNIVERSITARIO A GEMELLI IRCCS   (Italy)

Author keywords

Critical illness; Hypothalamic hormones; Intensive Care Units; Thyroid gland; Triiodothyronine

Indexed keywords

GROWTH HORMONE SECRETAGOGUE; HYPOTHALAMUS RELEASING FACTOR; LIOTHYRONINE; METHYLPREDNISOLONE; PLACEBO; PRALMORELIN; PROTIRELIN; THYROID HORMONE; THYROTROPIN; THYROXINE; VASOPRESSIN;

ACUTE KIDNEY FAILURE; BRAIN DEATH; BURN PATIENT; CLINICAL DECISION MAKING; CLINICAL TRIAL; CONTINUOUS INFUSION; CRITICAL ILLNESS; CRITICALLY ILL PATIENT; DISEASE SEVERITY; DRUG ABSORPTION; DRUG BLOOD LEVEL; DRUG MECHANISM; EUTHYROID SICK SYNDROME; HEART DISEASE; HORMONE BINDING; HUMAN; HYPOTHALAMUS; INFORMATION RETRIEVAL; INTENSIVE CARE UNIT; LIOTHYRONINE BLOOD LEVEL; ORGAN DONOR; PATHOGENESIS; PATHOPHYSIOLOGY; PROTEIN BINDING; RESPIRATORY FAILURE; REVIEW; STARVATION; THYROID DISEASE; THYROTROPIN BLOOD LEVEL; THYROTROPIN RELEASE; THYROXINE BLOOD LEVEL;

CRITICAL CARE; CRITICAL ILLNESS; EUTHYROID SICK SYNDROMES; HUMANS; HYPOTHALAMUS; THYROID DISEASES;

EID: 78649466896     PISSN: 03759393     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (68)

1. Van den Berghe G. Novel insights into the neuroendocrinology of critical illness. Eur J Endocrinol 2000;143:1-13.
2. Rubenfeld S. Euthyroid sick syndrome. N Engl J Med 1978;299:1414.
3. Wartofsky L, Burman KD. Alterations in thyroid function in patients with systemic illness: the "euthyroid sick syndrome". Endocr Rev 1982;3:164-217.
4. Chopra IJ. Euthyroid sick syndrome: abnormalities in circulating thyroid hormones and thyroid hormone physiology in nonthyroid illness (NTI). Med Grand Rounds 1982;1:201-12.
5. Chopra IJ. Clinical review 86: Euthyroid sick syndrome: is it a misnomer? J Clin Endocrinol Metab 1997;82:329-34.
6. Bermudez F, Surks MI, Oppenheimer JH. High incidence of decreased serum triiodothyronine concentration in patients with nonthyroidal disease. J Clin Endocrinol Metab 1975;41:27-40.
7. Kaplan MM, Larsen PR, Crantz FR, Dzau VJ, Rossing TH, Haddow JE. Prevalence of abnormal thyroid function test results in patients with acute medical illnesses. Am J Med 1982;72:9-16.
8. Kaptein EM, Weiner JM, Robinson WJ, Wheeler WS, Nicoloff JT. Relationship of altered thyroid hormone indices to survival in nonthyroidal illnesses. Clin Endocrinol (Oxf) 1982;16:565-74.
9. Slag MF, Morley JE, Elson MK, Crowson TW, Nuttall FQ, Shafer RB. Hypothyroxinemia in critically ill patients as a predictor of high mortality. JAMA 1981;245:43-5.
10. Rothwell PM, Lawler PG. Prediction of outcome in intensive care patients using endocrine parameters. Crit Care Med 1995;23:78-83.
11. Chinga-Alayo E, Villena J, Evans AT, Zimic M. Thyroid hormone levels improve the prediction of mortality among patients admitted to the intensive care unit. Intensive Care Med 2005;31:1356-61.
12. Rothwell PM, Udwadia ZF, Lawler PG. Thyrotropin concentration predicts outcome in critical illness. Anaesthesia 1993;48:373-6.
13. Sumita S, Ujike Y, Namiki A, Watanabe H, Kawamata M, Watanabe A et al. Suppression of the thyrotropin response to thyrotropin-releasing hormone and its association with severity of critical illness. Crit Care Med 1994;22:1603-9.
14. De Groot LJ. Dangerous dogmas in medicine: the nonthyroidal illness syndrome. J Clin Endocrinol Metab 1999;84:151-64.
15. Wartofsky L, Burman KD, Ringel MD. Trading one "dangerous dogma" for another? Thyroid hormone treatment of the "euthyroid sick syndrome". J Clin Endocrinol Metab 1999;84:1759-60.
16. Chopra IJ, Solomon DH, Teco GN, Eisenberg JB. An inhibitor of the binding of thyroid hormones to serum proteins is present in extrathyroidal tissues. Science 1982;215:407-9.
17. Romijn JA, Wiersinga WM. Decreased nocturnal surge of thyrotropin in nonthyroidal illness. J Clin Endocrinol Metab 1990;70:35-42.
18. Hamblin PS, Dyer SA, Mohr VS, Le Grand BA, Lim CF, Tuxen DV et al. Relationship between thyrotropin and thyroxine changes during recovery from severe hypothyroxinemia of critical illness. J Clin Endocrinol Metab 1986;62:717-22.
19. Spencer C, Eigen A, Shen D, Duda M, Qualls S, Weiss S et al. Specificity of sensitive assays of thyrotropin (TSH) used to screen for thyroid disease in hospitalized patients. Clin Chem 1987;33:1391-6.
20. Klein I, Ojamaa K. Thyroid hormone and the cardiovascular system. N Engl J Med 2001;344:501-9.
21. Ranklyn JA, Gammage MD, Ramsden DB, Sheppard MC. Thyroid status in patients after acute myocardial infarction. Clin Sci (Lond) 1984;67:585-90.
22. Hamilton MA, Stevenson LW, Luu M, Walden JA. Altered thyroid hormone metabolism in advanced heart failure. J Am Coll Cardiol 1990;16:91-5.
23. Pingitore A, Galli E, Barison A, Iervasi A, Scarlattini M, Nucci D et al. Acute effects of triiodothyronine (T3) replacement therapy in patients with chronic heart failure and low-T3 syndrome: a randomized, placebo-controlled study. J Clin Endocrinol Metab 2008;93:1351-8.
24. Klemperer JD, Klein I, Gomez M, Helm RE, Ojamaa K, Thomas SJ et al. Thyroid hormone treatment after coronary-artery bypass surgery. N Engl J Med 1995;333:1522-7.
25. Bennett-Guerrero E, Jimenez JL, White WD, D'Amico EB, Baldwin BI, Schwinn DA. Cardiovascular effects of intravenous triiodothyronine in patients undergoing coronary artery bypass graft surgery. A randomized, double-blind, placebo-controlled trial. Duke T3 study group. JAMA 1996;275:687-92.
26. Mullis-Jansson SL, Argenziano M, Corwin S, Homma S, Weinberg AD, Williams M et al. A randomized double-blind study of the effect of triiodothyronine on cardiac function and morbidity after coronary bypass surgery. J Thorac Cardiovasc Surg 1999;117:1128-34.
27. Bergeron GA, Goldsmith R, Schiller NB. Myocardial infarction, severe reversible ischemia, and shock following excess thyroid administration in a woman with normal coronary arteries. Arch Intern Med 1988;148:1450-3.
28. Wood KE, Becker BN, McCartney JG, D'Alessandro AM, Coursin DB. Care of the potential organ donor. N Engl J Med 2004;351:2730-9.
29. Novitzky D, Cooper DK, Morrell D, Isaacs S. Change from aerobic to anaerobic metabolism after brain death, and reversal following triiodothyronine therapy. Transplantation 1988;45:32-6.
30. Rosendale JD, Kauffman HM, McBride MA, Chabalewski FL, Zaroff JG, Garrity ER et al. Aggressive pharmacologic donor management results in more transplanted organs. Transplantation 2003;75:482-7.
31. Powner DJ, Hendrich A, Lagler RG, Ng RH, Madden RL. Hormonal changes in brain dead patients. Crit Care Med 1990;18:702-8.
32. Gramm HJ, Meinhold H, Bickel U, Zimmermann J, von Hammerstein B, Keller Fet al. Acute endocrine failure after brain death? Transplantation 1992;54:851-7.
33. Goarin JP, Cohen S, Riou B, Jacquens Y, Guesde R, Le Bret F et al. The effects of triiodothyronine on hemodynamic status and cardiac function in potential heart donors. Anesth Analg 1996;83:41-7.
34. Pérez-Blanco A, Caturla-Such J, Cánovas-Robles J, Sanchez-Payá J. Efficiency of triiodothyronine treatment on organ donor hemodynamic management and adenine nucleotide concentration. Intensive Care Med 2005;31:943-8.
35. Becker RA, Wilmore DW, Goodwin CW Jr, Zitzka CA, Wartofsky L, Burman KD et al. Free T4, free T3, and reverse T3 in critically ill, thermally injured patients. J Trauma 1980;20:713-21.
36. Gangemi EN, Garino F, Berchialla P, Martinese M, Arecco F, Orlandi Fet al. Low triiodothyronine serum levels as a predictor of poor prognosis in burn patients. Burns 2008;34:817-24.
37. Becker RA, Vaughan GM, Ziegler MG, Seraile LG, Goldfarb IW, Mansour EH et al. Hypermetabolic low triiodothyronine syndrome of burn injury. Crit Care Med 1982;10:870-5.
38. Siegel NJ, Gaudio KM, Katz LA, Reilly HF, Ardito TA, Hendler FG et al. Beneficial effect of thyroxin on recovery from toxic acute renal failure. Kidney Int 1984;25:906-11.
39. Cronin RE, Brown DM, Simonsen R. Protection by thyroxine in nephrotoxic acute renal failure. Am J Physiol 1986;251:408-16.
40. Sutter PM, Thulin G, Stromski M, Ardito T, Gaudio KM, Kashgarian M et al. Beneficial effect of thyroxin in the treatment of ischemic acute renal failure. Pediatr Nephrol 1988;2:1-7.
41. Acker CG, Singh AR, Flick RP, Bernardini J, Greenberg A, Johnson JP. A trial of thyroxine in acute renal failure. Kidney Int 2000;57:293-8.
42. Brent GA, Hershman JM. Thyroxine therapy in patients with severe nonthyroidal illnesses and low serum thyroxine concentration. J Clin Endocrinol Metab 1986;63:1-8.
43. Gardner DF, Kaplan MM, Stanley CA, Utiger RD. Effect of tri-iodothyronine replacement on the metabolic and pituitary responses to starvation. N Engl J Med 1979;300:579-84.
44. Pandya K, Lal C, Scheinhorn D, Day IK, Sharma OP. Hypothyroidism and ventilator dependency. Arch Intern Med 1989;149:2115-6.
45. Datta D, Scalise P. Hypothyroidism and failure to wean in patients receiving prolonged mechanical ventilation at a regional weaning center. Chest 2004;126:1307-12.
46. Ambrosino N, Pacini F, Paggiaro PL, Martino E, Contini V, Turini L et al. Impaired ventilatory drive in short-term primary hypothyroidism and its reversal by L-triiodothyronine. J Endocrinol Invest 1985;8:533-6.
47. Ladenson PW, Goldenheim PD, Ridgway EC. Prediction and reversal of blunted ventilatory responsiveness in patients with hypothyroidism. Am J Med 1988;84:877-83.
48. Gorini M, Spinelli A, Cangioli C, Gigliotti F, Duranti R, Arcangeli P et al. Control of breathing in patients with short-term primary hypothyroidism. Lung 1989;167:43-53.
49. Nordqvist P, Dhuner KG, Stenberg K, Orndahl G. Myxoedema coma and carbon dioxide-retention. Acta Med Scand 1960;166:189-94.
50. Massumi RA, Winnacker JL. Severe depression of the respiratory center in myxedema. Am J Med 1964;36:876-82.
51. Zwillich CW, Pierson DJ, Hofeldt FD, Lufkin EG, Weil JV. Ventilatory control in myxedema and hypothyroidism. N Engl J Med 1975;292:662-5.
52. Khaleeli AA, Edwards RH. Effect of treatment on skeletal muscle dysfunction in hypothyroidism. Clin Sci (Lond) 1984;66:63-8.
53. Laroche CM, Cairns T, Moxham J, Green M. Hypothyroidism presenting with respiratory muscle weakness. Am Rev Respir Dis 1988;138:472-4.
54. Martinez FJ, Bermudez-Gomez M, Celli BR. Hypothyroidism. A reversible cause of diaphragmatic dysfunction. Chest 1989;96:1059-63.
55. Siafakas NM, Salesiotou V, Filaditaki V, Tzanakis N, Thalassinos N, Bouros D. Respiratory muscle strength in hypothyroidism. Chest 1992;102:189-94.
56. Sachdev Y, Hall R. Effusions into body cavities in hypothyroidism. Lancet 1975;1:564-6.
57. Rajagopal KR, Abbrecht PH, Derderian SS, Pickett C, Hofeldt F, Tellis CJ et al. Obstructive sleep apnea in hypothyroidism. Ann Intern Med 1984;101:491-4.
58. Plikat K, Langgartner J, Buettner R, Bollheimer LC, Woenckhaus U, Schölmerich J et al. Frequency and outcome of patients with nonthyroidal illness syndrome in a medical intensive care unit. Metabolism 2007;56:239-44.
59. Bello G, Pennisi MA, Montini L, Silva S, Maviglia R, Cavallaro Fet al. Nonthyroidal illness syndrome and prolonged mechanical ventilation in patients admitted to the intensive care unit. Chest 2009;135:1448-54.
60. Liers E, Guldenaar SE, Wiersinga WM, Swaab DF. Decreased hypothalamic thyrotropin-releasing hormone gene expression in patients with non-thyroidal illness. J Clin Endocrinol Metab 1997;82:4032-6.
61. Van den Berghe G, de Zegher F, Baxter RC, Veldhuis JD, Wouters P, Schetz M et al. Neuroendocrinology of prolonged critical illness: effects of exogenous thyrotropin-releasing hormone and its combination with growth hormone secretagogues. J Clin Endocrinol Metab 1998;83:309-19.
62. Van den Berghe G, Wouters P, Bowers CY, de Zegher F, Bouillon R, Veldhuis JD. Growth hormone-releasing peptide-2 infusion synchronizes growth hormone, thyrotrophin and prolactin release in prolonged critical illness. Eur J Endocrinol 1999;140:17-22.
63. Van den Berghe G, Wouters P, Weekers F, Mohan S, Baxter RC, Veldhuis JD et al. Reactivation of pituitary hormone release and metabolic improvement by infusion of growth hormone-releasing peptide and thyrotropin-releasing hormone in patients with protracted critical illness. J Clin Endocrinol Metab 1999;84:1311-23.
64. Arem R, Wiener GJ, Kaplan SG, Kim HS, Reichlin S, Kaplan MM. Reduced tissue thyroid hormone levels in fatal illness. Metabolism 1993;42:1102-8.
65. Benvenga S, Bartolone L, Squadrito S, Lo Giudice F, Trimarchi F. Delayed intestinal absorption of levothyroxine. Thyroid 1995;5:249-53.
66. Liel Y, Sperber AD, Shany S. Nonspecific intestinal adsorption of levothyroxine by aluminum hydroxide. Am J Med 1994;97:363-5.
67. Sherman SI, Malecha SE. Absorption and Malabsorption of Levothyroxine Sodium. Am J Ther 1995;2:814-8.
68. Singh N, Weisler SL, Hershman JM. The acute effect of calcium carbonate on the intestinal absorption of levothyroxine. Thyroid 2001;11:967-71.